Renal Dehydropeptidase Inhibitor [EPC]

92 reported adverse events

Drugs of this class: IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS

These side effects are most commonly reported by patients taking drugs of the Renal Dehydropeptidase Inhibitor [EPC] class:

# Side effect Count
See all common reactions for Renal Dehydropeptidase Inhibitor [EPC]

Drugs of the Renal Dehydropeptidase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
See all enriched reactions for Renal Dehydropeptidase Inhibitor [EPC]